Skip Navigation

Human Reproduction 2005 20(2):573-574; doi:10.1093/humrep/deh623
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kailasam, C.
Right arrow Articles by Jenkins, J.M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kailasam, C.
Right arrow Articles by Jenkins, J.M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction vol. 20 no. 2 © European Society of Human Reproduction and Embryology 2004; all rights reserved

Reply to ‘Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome’

C. Kailasam1, S.D. Keay, P. Wilson, W.C. Ford and J.M. Jenkins

Centre for Reproductive Medicine, University of Bristol, 4 Priory Road, Clifton, Bristol, BS9 4HU, UK

1 Email: chandra.kailasam{at}repromed-bristol.co.uk

Sir,

We are very grateful to Klinkert et al. for drawing attention to the potential confounding effect of the different starting doses of FSH dependent on age. In our initial paper (Kailasam et al., 2004Go), we had chosen to present the statistics as simply as possible to illustrate our key message that in defining poor response one must consider both the response and the degree of stimulation. However, this letter provides us with the opportunity to present further analyses illustrating that this point remains true irrespective of age up to 40 years.

There is no doubt that ovarian responsiveness declines with age. Our point is that if there is a satisfactory response to the higher dose of gonadotrophin, couples retain a good chance of success despite being aged up to 40 years, whereas failure to respond to a high FSH dose is associated with a poor outcome whatever the woman's age.

Splitting the analysis of the effect of FSH dose and number of eggs recovered shown in Table III of our original paper (Kailasam et al. 2004Go) into women <35 years versus ≥35 years yields Table I.


View this table:
[in this window]
[in a new window]
 
Table III. Pregnancy ratesa in women aged <40 years in their first cycle of IVF according to cumulative dose of FSH and number of oocytes retrieved

 

View this table:
[in this window]
[in a new window]
 
Table I.

 
This illustrates that the association between the clinical pregnancy rate and the number of eggs recovered related to total FSH dose required is remarkably similar in women above and below 35 years of age.

We used logistic regression to test further the effects of age, total dose of FSH and the number of oocytes recovered. The program (SPSS) was offered the following categorical variables: age <35 years (reference) versus ≥35 years; oocytes recovered >4 (reference) versus ≤4; FSH dose ≤3000 IU (reference) versus >3000 IU plus all possible interaction terms. Models were derived by forward selection using the likelihood ratio statistic based on maximum likelihood estimates.

Forward selection derived a model where the only significant predictors were the dose of FSH and the number of eggs recovered (Table II).


View this table:
[in this window]
[in a new window]
 
Table II. Significant predictors of clinical pregnancy identified by logistic regression using forward selection

 
Although it has been suggested that the maximum dose for all patients should be 150 IU, many may feel otherwise and suggest benefit up to 300 IU of FSH daily.

In our study, patients whose cycles were cancelled for poor ovarian response on an initial gonadotrophin dose of <300 IU had a clinical pregnancy rate of 22% during a subsequent cycle when the dose of gonadotrophins was increased to 300 IU, thereby suggesting a beneficial effect.

In conclusion, poor response to ovarian stimulation is more common in women >35 years but is not confined to them. At least up to 40 years of age, definition of the response including the dose of gonadotrophin provides a more accurate prognosis for pregnancy than age.

References

Kailasam C, Keay SD, Wilson P, Ford WC and Jenkins JM (2004) Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome. Hum Reprod 19, 1544–1547.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kailasam, C.
Right arrow Articles by Jenkins, J.M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kailasam, C.
Right arrow Articles by Jenkins, J.M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?